| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |